Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AYUSH
    • Ayurveda witnesses...

    Ayurveda witnesses global resurgence; Market size to touch 8 billion dollars by 2022: Shripad

    Written by Ruby Khatun Khatun Published On 2017-10-18T09:57:57+05:30  |  Updated On 18 Oct 2017 9:57 AM IST
    Ayurveda witnesses global resurgence; Market size to touch 8 billion dollars by 2022: Shripad

    New Delhi: Minister of State for AYUSH Shripad Yesso Naik on Monday said a threefold increase in market size of Ayurvedic products from 2.5 billion to 8 billion dollars is envisioned by 2022.


    Speaking at the Ayurveda Conclave organized by the Ministry of AYUSH and Confederation of Indian Industry (CII), he said: “Ayurveda is witnessing a resurgence in India and around the globe. It advocates preventive healthcare methods of treatment; it is not a system of medicine, but a science of life and longevity.”


    The AYUSH Ministry was established in 2014 to promote indigenous healing systems and its priorities include education, standardization of drugs, and enhancement of availability of raw materials, R&D, communications and larger involvement in the national system for delivering healthcare.


    “The government has already begun work on building AIIMS like facilities for Ayurveda across India. To converge the research approach of AYUSH systems with the modern system of medicine, the Ministry of AYUSH and Indian Council of Medicinal Research have decided to have molecular-based studies on specific leads from the Ministry,” observed Mr Naik.


    Dr Rajesh Kotecha, Secretary, Ministry of AYUSH, said, “We have to look at research integration and teaching.” Entrepreneurs must leverage the huge demand for Ayurveda, he added, noting that GST has been brought down to 5 percent to encourage the sectors.


    The healthcare market in India is estimated to grow at a compound annual growth rate of 23 percent from 2015 to 2020 and is expected to be a 280 billion dollar market by 2020.


    Shobana Kamineni, President, CII & Vice Chairperson, Apollo Hospital Enterprise, noted that only 10 percent of the Indian population goes to Ayurvedic centres. “Ayurveda’s rich heritage and recognition as an alternative system of medicine in developed countries provides a good foundation to set an ambitious growth goal defined by increasing by market share, customer access, and profitability in both India and global markets,” she said.

    AyurvedaAyurvedic productsAyushAyush MinistryCIIConfederation of Indian IndustryDr Rajesh Kotechaglobal resurgenceHealthcareHealthcare NewsmarketMinister of State for AYUSHShobana KamineniShripadShripad NaikShripad Yesso Naik
    Source : UNI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok